Cargando…
Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma
As a clinical setting in which novel treatment options are urgently needed, hepatocellular carcinoma (HCC) exhibits intriguing opportunities for oncolytic virotherapy. Here we report the rational generation of a novel herpes simplex virus type 1 (HSV-1)-based oncolytic vector for targeting HCC, name...
Autores principales: | Luo, Yong, Lin, Chaolong, Ren, Wenfeng, Ju, Fei, Xu, Zilong, Liu, Huiling, Yu, Zeng, Chen, Jun, Zhang, Jun, Liu, Pingguo, Huang, Chenghao, Xia, Ningshao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838930/ https://www.ncbi.nlm.nih.gov/pubmed/31720372 http://dx.doi.org/10.1016/j.omto.2019.09.004 |
Ejemplares similares
-
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
por: Luo, Yong, et al.
Publicado: (2020) -
Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
por: Yura, Yoshiaki
Publicado: (2017) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017) -
Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)